GNOM
Global X Genomics & Biotechnology ETF
Price Chart
Latest Quote
$52.23
+0.47 (+0.90%)
Current Price
| Previous Close | $51.76 |
| Open | $51.30 |
| Day High | $52.97 |
| Day Low | $51.30 |
| Volume | 54,934 |
Fund Information
| Quarterly Dividend / Yield | N/A / 1.26% |
| Net Assets | $55.79M |
| Expense Ratio | 0.50% |
| Category | Health |
| Fund Family | Global X Funds |
| Net Asset Value | $51.67 |
| Premium/Discount | 1.08% |
| Quarterly Dividend Yield | 1.26% |
| Exchange | NGM |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $49.46 |
| SMA50 | $47.35 |
| SMA200 | $44.83 |
| RSI | 65.87 |
| ATR | 1.5125 |
| Rel Volume | 2.71 |
Performance History
| Week | +4.25% |
| Month | +12.65% |
| Quarter | +22.09% |
| 6 Months | +15.59% |
| YTD | +14.37% |
| Year | +62.22% |
| 3 Years | +2.61% |
| 5 Years | -42.00% |
| 10 Years | -13.73% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $52.23 | 55,200 |
| 2026-06-22 | $51.76 | 67,900 |
| 2026-06-18 | $52.07 | 13,700 |
| 2026-06-17 | $51.30 | 16,300 |
| 2026-06-16 | $50.01 | 7,200 |
| 2026-06-15 | $50.10 | 12,100 |
| 2026-06-12 | $48.95 | 25,300 |
| 2026-06-11 | $49.13 | 7,600 |
| 2026-06-10 | $47.92 | 14,000 |
| 2026-06-09 | $48.90 | 9,200 |
| 2026-06-08 | $47.78 | 11,400 |
| 2026-06-05 | $48.56 | 6,400 |
| 2026-06-04 | $50.71 | 28,500 |
| 2026-06-03 | $49.01 | 5,500 |
| 2026-06-02 | $48.05 | 13,800 |
| 2026-06-01 | $48.53 | 9,300 |
| 2026-05-29 | $49.68 | 66,700 |
| 2026-05-28 | $49.51 | 13,500 |
| 2026-05-27 | $47.96 | 18,500 |
| 2026-05-26 | $47.02 | 5,200 |
About Global X Genomics & Biotechnology ETF
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.